Rare Medical News
Chimeric antigen receptor (CAR) T cell therapy is a type of cellular immunotherapy that changes T cells so they are able to recognize and attack cancer
5 Facts you should know
Chimeric antigen receptor (CAR) T-cell therapy is a technology that can genetically engineer immune cells T cells for use in immunotherapy
Chimeric antigen receptors are receptor proteins that have been engineered to give T cells the new ability to target a specific protein
The receptors are chimeric because they combine both antigen-binding and T cell activating functions into a single receptor
The CAR T-cell therapies approved by FDA to date target one of two antigens on B cells, CD19 or BCM
All currently available CAR T-cell therapies are allogeneic – and customized for each individual patient
Interest over time
CAR-T therapy is also known as…
CAR-T cell therapyChimeric antigen receptor T cell CAR-T gene therapy
What’s your Rare IQ?
What’s the most commonly seem serious side effect with CAR-T cell therapy?